nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—PLA2G4A—Hydrolysis of LPC—PLA2G4F—Crohn's disease	0.018	0.093	CbGpPWpGaD
Epirubicin—CHD1—mammalian vulva—Crohn's disease	0.0118	0.0745	CbGeAlD
Epirubicin—CHD1—lymphoid tissue—Crohn's disease	0.0105	0.0662	CbGeAlD
Epirubicin—PLA2G4A—Acyl chain remodelling of PI—PLA2G4F—Crohn's disease	0.0103	0.0534	CbGpPWpGaD
Epirubicin—PLA2G4A—Acyl chain remodelling of PG—PLA2G4F—Crohn's disease	0.00983	0.0509	CbGpPWpGaD
Epirubicin—PLA2G4A—Acyl chain remodelling of PS—PLA2G4F—Crohn's disease	0.00983	0.0509	CbGpPWpGaD
Epirubicin—AURKA—mammalian vulva—Crohn's disease	0.00951	0.0601	CbGeAlD
Epirubicin—DHCR7—skin of body—Crohn's disease	0.00872	0.0551	CbGeAlD
Epirubicin—AURKA—lymphoid tissue—Crohn's disease	0.00844	0.0533	CbGeAlD
Epirubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—TBC1D1—Crohn's disease	0.00842	0.0436	CbGpPWpGaD
Epirubicin—AURKA—digestive system—Crohn's disease	0.00834	0.0527	CbGeAlD
Epirubicin—YWHAG—smooth muscle tissue—Crohn's disease	0.00811	0.0512	CbGeAlD
Epirubicin—DHCR7—mammalian vulva—Crohn's disease	0.00795	0.0502	CbGeAlD
Epirubicin—PLA2G4A—Acyl chain remodelling of PE—PLA2G4F—Crohn's disease	0.00772	0.0399	CbGpPWpGaD
Epirubicin—YWHAG—mammalian vulva—Crohn's disease	0.0073	0.0461	CbGeAlD
Epirubicin—PLA2G4A—Acyl chain remodelling of PC—PLA2G4F—Crohn's disease	0.00722	0.0374	CbGpPWpGaD
Epirubicin—DHCR7—lymphoid tissue—Crohn's disease	0.00706	0.0446	CbGeAlD
Epirubicin—DHCR7—digestive system—Crohn's disease	0.00698	0.0441	CbGeAlD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.00692	0.0358	CbGpPWpGaD
Epirubicin—YWHAG—lymphoid tissue—Crohn's disease	0.00648	0.0409	CbGeAlD
Epirubicin—YWHAG—FoxO family signaling—MST1—Crohn's disease	0.00647	0.0335	CbGpPWpGaD
Epirubicin—YWHAG—digestive system—Crohn's disease	0.0064	0.0404	CbGeAlD
Epirubicin—PLA2G4A—smooth muscle tissue—Crohn's disease	0.00605	0.0382	CbGeAlD
Epirubicin—CHD1—lymph node—Crohn's disease	0.00591	0.0373	CbGeAlD
Epirubicin—UGT2B7—digestive system—Crohn's disease	0.00578	0.0365	CbGeAlD
Epirubicin—PLA2G4A—mammalian vulva—Crohn's disease	0.00544	0.0344	CbGeAlD
Epirubicin—TOP2A—mammalian vulva—Crohn's disease	0.00517	0.0327	CbGeAlD
Epirubicin—YWHAG—ErbB1 downstream signaling—KSR1—Crohn's disease	0.00499	0.0258	CbGpPWpGaD
Epirubicin—AURKA—lymph node—Crohn's disease	0.00476	0.0301	CbGeAlD
Epirubicin—YWHAG—ErbB1 downstream signaling—PPP5C—Crohn's disease	0.00464	0.024	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—KSR1—Crohn's disease	0.00434	0.0225	CbGpPWpGaD
Epirubicin—YWHAG—IL3-mediated signaling events—IL3—Crohn's disease	0.00422	0.0218	CbGpPWpGaD
Epirubicin—TOP2A—Methyldopa—Mesalazine—Crohn's disease	0.00404	0.487	CbGdCrCtD
Epirubicin—DHCR7—lymph node—Crohn's disease	0.00398	0.0252	CbGeAlD
Epirubicin—YWHAG—lymph node—Crohn's disease	0.00366	0.0231	CbGeAlD
Epirubicin—YWHAG—Membrane Trafficking—TBC1D1—Crohn's disease	0.00339	0.0176	CbGpPWpGaD
Epirubicin—ABCC1—mammalian vulva—Crohn's disease	0.00311	0.0197	CbGeAlD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—ZMIZ1—Crohn's disease	0.00295	0.0153	CbGpPWpGaD
Epirubicin—AURKA—APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1—UBE2D1—Crohn's disease	0.00281	0.0146	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.00276	0.0143	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.00275	0.0143	CbGpPWpGaD
Epirubicin—PLA2G4A—lymph node—Crohn's disease	0.00273	0.0172	CbGeAlD
Epirubicin—PLA2G4A—Glycerophospholipid biosynthesis—PLA2G4F—Crohn's disease	0.00264	0.0137	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—KSR1—Crohn's disease	0.00263	0.0136	CbGpPWpGaD
Epirubicin—TOP2A—lymph node—Crohn's disease	0.00259	0.0164	CbGeAlD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00257	0.0133	CbGpPWpGaD
Epirubicin—AURKA—APC/C-mediated degradation of cell cycle proteins—UBE2D1—Crohn's disease	0.00244	0.0127	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00205	0.0106	CbGpPWpGaD
Epirubicin—YWHAG—IL3-mediated signaling events—JAK2—Crohn's disease	0.00199	0.0103	CbGpPWpGaD
Epirubicin—PLA2G4A—Phospholipid metabolism—PLA2G4F—Crohn's disease	0.00184	0.00953	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00175	0.00906	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—CREM—Crohn's disease	0.00157	0.00814	CbGpPWpGaD
Epirubicin—PLA2G4A—Phospholipid metabolism—MTMR3—Crohn's disease	0.00156	0.0081	CbGpPWpGaD
Epirubicin—ABCC1—lymph node—Crohn's disease	0.00156	0.00985	CbGeAlD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00152	0.00788	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—PTPN2—Crohn's disease	0.00151	0.00781	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—Crohn's disease	0.00151	0.182	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—Crohn's disease	0.00151	0.182	CbGdCrCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00149	0.0077	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	0.00133	0.00688	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00132	0.00683	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—Crohn's disease	0.00124	0.149	CbGdCrCtD
Epirubicin—ABCC1—S1P1 pathway—PTGS2—Crohn's disease	0.0012	0.0062	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00116	0.006	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—SMAD3—Crohn's disease	0.0011	0.0057	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00109	0.00562	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.00104	0.00539	CbGpPWpGaD
Epirubicin—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000972	0.00152	CcSEcCtD
Epirubicin—Bronchitis—Mesalazine—Crohn's disease	0.000964	0.0015	CcSEcCtD
Epirubicin—UGT2B7—Metapathway biotransformation—GPX4—Crohn's disease	0.000963	0.00498	CbGpPWpGaD
Epirubicin—Amenorrhoea—Prednisone—Crohn's disease	0.000962	0.0015	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000956	0.00149	CcSEcCtD
Epirubicin—Pancytopenia—Mesalazine—Crohn's disease	0.000951	0.00149	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—SMAD3—Crohn's disease	0.000946	0.0049	CbGpPWpGaD
Epirubicin—Dysuria—Mesalazine—Crohn's disease	0.000937	0.00146	CcSEcCtD
Epirubicin—Neutropenia—Mesalazine—Crohn's disease	0.000937	0.00146	CcSEcCtD
Epirubicin—Viral infection—Prednisone—Crohn's disease	0.000935	0.00146	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000931	0.00145	CcSEcCtD
Epirubicin—Arthropathy—Prednisone—Crohn's disease	0.000929	0.00145	CcSEcCtD
Epirubicin—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000928	0.00145	CcSEcCtD
Epirubicin—Pollakiuria—Mesalazine—Crohn's disease	0.000926	0.00145	CcSEcCtD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—Crohn's disease	0.00092	0.00476	CbGpPWpGaD
Epirubicin—Agranulocytosis—Azathioprine—Crohn's disease	0.000915	0.00143	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PTPN2—Crohn's disease	0.000915	0.00473	CbGpPWpGaD
Epirubicin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000915	0.00143	CcSEcCtD
Epirubicin—Decreased appetite—Mercaptopurine—Crohn's disease	0.000913	0.00143	CcSEcCtD
Epirubicin—Weight increased—Mesalazine—Crohn's disease	0.000912	0.00142	CcSEcCtD
Epirubicin—Weight decreased—Mesalazine—Crohn's disease	0.000906	0.00142	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000906	0.00142	CcSEcCtD
Epirubicin—Pneumonia—Mesalazine—Crohn's disease	0.000899	0.0014	CcSEcCtD
Epirubicin—Infestation NOS—Mesalazine—Crohn's disease	0.000893	0.0014	CcSEcCtD
Epirubicin—Infestation—Mesalazine—Crohn's disease	0.000893	0.0014	CcSEcCtD
Epirubicin—Ulcer—Prednisone—Crohn's disease	0.000893	0.0014	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000886	0.00138	CcSEcCtD
Epirubicin—Haemoglobin—Azathioprine—Crohn's disease	0.000885	0.00138	CcSEcCtD
Epirubicin—Haemorrhage—Azathioprine—Crohn's disease	0.00088	0.00138	CcSEcCtD
Epirubicin—Renal failure—Mesalazine—Crohn's disease	0.000878	0.00137	CcSEcCtD
Epirubicin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000876	0.00137	CcSEcCtD
Epirubicin—Stomatitis—Mesalazine—Crohn's disease	0.000871	0.00136	CcSEcCtD
Epirubicin—Jaundice—Mesalazine—Crohn's disease	0.000871	0.00136	CcSEcCtD
Epirubicin—Conjunctivitis—Mesalazine—Crohn's disease	0.000868	0.00136	CcSEcCtD
Epirubicin—Urinary tract infection—Mesalazine—Crohn's disease	0.000868	0.00136	CcSEcCtD
Epirubicin—Sweating—Mesalazine—Crohn's disease	0.000856	0.00134	CcSEcCtD
Epirubicin—Haematuria—Mesalazine—Crohn's disease	0.000852	0.00133	CcSEcCtD
Epirubicin—Hiccups—Prednisone—Crohn's disease	0.000845	0.00132	CcSEcCtD
Epirubicin—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000845	0.00132	CcSEcCtD
Epirubicin—Epistaxis—Mesalazine—Crohn's disease	0.000843	0.00132	CcSEcCtD
Epirubicin—Sinusitis—Mesalazine—Crohn's disease	0.000838	0.00131	CcSEcCtD
Epirubicin—Agranulocytosis—Mesalazine—Crohn's disease	0.000834	0.0013	CcSEcCtD
Epirubicin—Erythema multiforme—Azathioprine—Crohn's disease	0.000832	0.0013	CcSEcCtD
Epirubicin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00083	0.0013	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.000815	0.00422	CbGpPWpGaD
Epirubicin—Skin exfoliation—Prednisone—Crohn's disease	0.000807	0.00126	CcSEcCtD
Epirubicin—Haemoglobin—Mesalazine—Crohn's disease	0.000806	0.00126	CcSEcCtD
Epirubicin—Rhinitis—Mesalazine—Crohn's disease	0.000804	0.00126	CcSEcCtD
Epirubicin—Fluid retention—Prednisone—Crohn's disease	0.000802	0.00125	CcSEcCtD
Epirubicin—Haemorrhage—Mesalazine—Crohn's disease	0.000802	0.00125	CcSEcCtD
Epirubicin—Hepatitis—Mesalazine—Crohn's disease	0.000802	0.00125	CcSEcCtD
Epirubicin—Pharyngitis—Mesalazine—Crohn's disease	0.000796	0.00124	CcSEcCtD
Epirubicin—Immune system disorder—Azathioprine—Crohn's disease	0.000795	0.00124	CcSEcCtD
Epirubicin—Mediastinal disorder—Azathioprine—Crohn's disease	0.000793	0.00124	CcSEcCtD
Epirubicin—Neuropathy—Prednisone—Crohn's disease	0.000793	0.00124	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000793	0.0041	CbGpPWpGaD
Epirubicin—Urinary tract disorder—Mesalazine—Crohn's disease	0.000792	0.00124	CcSEcCtD
Epirubicin—Oedema peripheral—Mesalazine—Crohn's disease	0.00079	0.00123	CcSEcCtD
Epirubicin—Chills—Azathioprine—Crohn's disease	0.00079	0.00123	CcSEcCtD
Epirubicin—Connective tissue disorder—Mesalazine—Crohn's disease	0.000788	0.00123	CcSEcCtD
Epirubicin—Arrhythmia—Azathioprine—Crohn's disease	0.000786	0.00123	CcSEcCtD
Epirubicin—Urethral disorder—Mesalazine—Crohn's disease	0.000786	0.00123	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PLA2G4F—Crohn's disease	0.00078	0.00404	CbGpPWpGaD
Epirubicin—Alopecia—Azathioprine—Crohn's disease	0.000778	0.00122	CcSEcCtD
Epirubicin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000773	0.00121	CcSEcCtD
Epirubicin—Oesophagitis—Prednisone—Crohn's disease	0.000772	0.00121	CcSEcCtD
Epirubicin—Ecchymosis—Prednisone—Crohn's disease	0.000764	0.00119	CcSEcCtD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Crohn's disease	0.00076	0.00393	CbGpPWpGaD
Epirubicin—Erythema multiforme—Mesalazine—Crohn's disease	0.000758	0.00118	CcSEcCtD
Epirubicin—Pulmonary oedema—Prednisone—Crohn's disease	0.000752	0.00117	CcSEcCtD
Epirubicin—Eye disorder—Mesalazine—Crohn's disease	0.000749	0.00117	CcSEcCtD
Epirubicin—Tinnitus—Mesalazine—Crohn's disease	0.000748	0.00117	CcSEcCtD
Epirubicin—Cardiac disorder—Mesalazine—Crohn's disease	0.000744	0.00116	CcSEcCtD
Epirubicin—Sepsis—Prednisone—Crohn's disease	0.000733	0.00115	CcSEcCtD
Epirubicin—Angiopathy—Mesalazine—Crohn's disease	0.000728	0.00114	CcSEcCtD
Epirubicin—Immune system disorder—Mesalazine—Crohn's disease	0.000724	0.00113	CcSEcCtD
Epirubicin—Mediastinal disorder—Mesalazine—Crohn's disease	0.000723	0.00113	CcSEcCtD
Epirubicin—Chills—Mesalazine—Crohn's disease	0.00072	0.00112	CcSEcCtD
Epirubicin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000718	0.00112	CcSEcCtD
Epirubicin—Ill-defined disorder—Azathioprine—Crohn's disease	0.000711	0.00111	CcSEcCtD
Epirubicin—Alopecia—Mesalazine—Crohn's disease	0.000709	0.00111	CcSEcCtD
Epirubicin—Thrombophlebitis—Prednisone—Crohn's disease	0.000709	0.00111	CcSEcCtD
Epirubicin—Anaemia—Azathioprine—Crohn's disease	0.000708	0.00111	CcSEcCtD
Epirubicin—Diabetes mellitus—Prednisone—Crohn's disease	0.000705	0.0011	CcSEcCtD
Epirubicin—Mental disorder—Mesalazine—Crohn's disease	0.000703	0.0011	CcSEcCtD
Epirubicin—Erythema—Mesalazine—Crohn's disease	0.000698	0.00109	CcSEcCtD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000692	0.00358	CbGpPWpGaD
Epirubicin—Malaise—Azathioprine—Crohn's disease	0.000691	0.00108	CcSEcCtD
Epirubicin—Flatulence—Mesalazine—Crohn's disease	0.000688	0.00107	CcSEcCtD
Epirubicin—Leukopenia—Azathioprine—Crohn's disease	0.000686	0.00107	CcSEcCtD
Epirubicin—Vascular purpura—Prednisone—Crohn's disease	0.000686	0.00107	CcSEcCtD
Epirubicin—Tension—Mesalazine—Crohn's disease	0.000685	0.00107	CcSEcCtD
Epirubicin—Dysgeusia—Mesalazine—Crohn's disease	0.000684	0.00107	CcSEcCtD
Epirubicin—Nervousness—Mesalazine—Crohn's disease	0.000678	0.00106	CcSEcCtD
Epirubicin—Cardiac failure congestive—Prednisone—Crohn's disease	0.000676	0.00106	CcSEcCtD
Epirubicin—Back pain—Mesalazine—Crohn's disease	0.000675	0.00105	CcSEcCtD
Epirubicin—Muscle spasms—Mesalazine—Crohn's disease	0.000671	0.00105	CcSEcCtD
Epirubicin—Vomiting—Mercaptopurine—Crohn's disease	0.000667	0.00104	CcSEcCtD
Epirubicin—DHCR7—Metabolism—MTMR3—Crohn's disease	0.000663	0.00343	CbGpPWpGaD
Epirubicin—Rash—Mercaptopurine—Crohn's disease	0.000662	0.00103	CcSEcCtD
Epirubicin—Dermatitis—Mercaptopurine—Crohn's disease	0.000661	0.00103	CcSEcCtD
Epirubicin—PLA2G4A—PDGF Pathway—STAT3—Crohn's disease	0.000658	0.00341	CbGpPWpGaD
Epirubicin—Vision blurred—Mesalazine—Crohn's disease	0.000658	0.00103	CcSEcCtD
Epirubicin—Increased appetite—Prednisone—Crohn's disease	0.000653	0.00102	CcSEcCtD
Epirubicin—Arthralgia—Azathioprine—Crohn's disease	0.000652	0.00102	CcSEcCtD
Epirubicin—Myalgia—Azathioprine—Crohn's disease	0.000652	0.00102	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000648	0.00101	CcSEcCtD
Epirubicin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000648	0.00101	CcSEcCtD
Epirubicin—Anaemia—Mesalazine—Crohn's disease	0.000645	0.00101	CcSEcCtD
Epirubicin—Discomfort—Azathioprine—Crohn's disease	0.000645	0.00101	CcSEcCtD
Epirubicin—Purpura—Prednisone—Crohn's disease	0.000636	0.000994	CcSEcCtD
Epirubicin—Malaise—Mesalazine—Crohn's disease	0.00063	0.000983	CcSEcCtD
Epirubicin—Cardiac failure—Prednisone—Crohn's disease	0.000628	0.000982	CcSEcCtD
Epirubicin—Vertigo—Mesalazine—Crohn's disease	0.000627	0.00098	CcSEcCtD
Epirubicin—Syncope—Mesalazine—Crohn's disease	0.000626	0.000978	CcSEcCtD
Epirubicin—Lethargy—Prednisone—Crohn's disease	0.000626	0.000978	CcSEcCtD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—JAK2—Crohn's disease	0.000625	0.00323	CbGpPWpGaD
Epirubicin—Leukopenia—Mesalazine—Crohn's disease	0.000625	0.000976	CcSEcCtD
Epirubicin—Nausea—Mercaptopurine—Crohn's disease	0.000624	0.000974	CcSEcCtD
Epirubicin—Infection—Azathioprine—Crohn's disease	0.000621	0.000971	CcSEcCtD
Epirubicin—Palpitations—Mesalazine—Crohn's disease	0.000617	0.000964	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000617	0.00319	CbGpPWpGaD
Epirubicin—Loss of consciousness—Mesalazine—Crohn's disease	0.000614	0.000958	CcSEcCtD
Epirubicin—Osteoarthritis—Prednisone—Crohn's disease	0.000613	0.000958	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000613	0.000958	CcSEcCtD
Epirubicin—Thrombocytopenia—Azathioprine—Crohn's disease	0.000612	0.000957	CcSEcCtD
Epirubicin—PLA2G4A—Endothelins—JAK2—Crohn's disease	0.000611	0.00316	CbGpPWpGaD
Epirubicin—Cough—Mesalazine—Crohn's disease	0.000609	0.000951	CcSEcCtD
Epirubicin—Skin disorder—Azathioprine—Crohn's disease	0.000608	0.000949	CcSEcCtD
Epirubicin—Affect lability—Prednisone—Crohn's disease	0.000604	0.000943	CcSEcCtD
Epirubicin—Hypertension—Mesalazine—Crohn's disease	0.000603	0.000941	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	0.000596	0.00308	CbGpPWpGaD
Epirubicin—Arthralgia—Mesalazine—Crohn's disease	0.000594	0.000928	CcSEcCtD
Epirubicin—Myalgia—Mesalazine—Crohn's disease	0.000594	0.000928	CcSEcCtD
Epirubicin—Chest pain—Mesalazine—Crohn's disease	0.000594	0.000928	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000593	0.00307	CbGpPWpGaD
Epirubicin—Anxiety—Mesalazine—Crohn's disease	0.000592	0.000925	CcSEcCtD
Epirubicin—Face oedema—Prednisone—Crohn's disease	0.000592	0.000925	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00059	0.000922	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—JAK2—Crohn's disease	0.000589	0.00305	CbGpPWpGaD
Epirubicin—Discomfort—Mesalazine—Crohn's disease	0.000587	0.000917	CcSEcCtD
Epirubicin—Hypotension—Azathioprine—Crohn's disease	0.000584	0.000913	CcSEcCtD
Epirubicin—Cardiac arrest—Prednisone—Crohn's disease	0.000583	0.000911	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—JAK2—Crohn's disease	0.000583	0.00302	CbGpPWpGaD
Epirubicin—Dry mouth—Mesalazine—Crohn's disease	0.000581	0.000908	CcSEcCtD
Epirubicin—Mood swings—Prednisone—Crohn's disease	0.000581	0.000907	CcSEcCtD
Epirubicin—Confusional state—Mesalazine—Crohn's disease	0.000574	0.000897	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00057	0.00089	CcSEcCtD
Epirubicin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00057	0.00089	CcSEcCtD
Epirubicin—Oedema—Mesalazine—Crohn's disease	0.00057	0.00089	CcSEcCtD
Epirubicin—Infection—Mesalazine—Crohn's disease	0.000566	0.000884	CcSEcCtD
Epirubicin—Dry skin—Prednisone—Crohn's disease	0.000562	0.000878	CcSEcCtD
Epirubicin—Shock—Mesalazine—Crohn's disease	0.000561	0.000876	CcSEcCtD
Epirubicin—Nervous system disorder—Mesalazine—Crohn's disease	0.000559	0.000873	CcSEcCtD
Epirubicin—Hypokalaemia—Prednisone—Crohn's disease	0.000558	0.000872	CcSEcCtD
Epirubicin—Thrombocytopenia—Mesalazine—Crohn's disease	0.000558	0.000871	CcSEcCtD
Epirubicin—Tachycardia—Mesalazine—Crohn's disease	0.000556	0.000869	CcSEcCtD
Epirubicin—Skin disorder—Mesalazine—Crohn's disease	0.000553	0.000864	CcSEcCtD
Epirubicin—ABCC1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000553	0.00286	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000551	0.00086	CcSEcCtD
Epirubicin—Anorexia—Mesalazine—Crohn's disease	0.000543	0.000848	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000541	0.000845	CcSEcCtD
Epirubicin—Muscular weakness—Prednisone—Crohn's disease	0.000541	0.000845	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00054	0.000843	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000534	0.00277	CbGpPWpGaD
Epirubicin—Abdominal distension—Prednisone—Crohn's disease	0.000534	0.000834	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—UBE2D1—Crohn's disease	0.000533	0.00276	CbGpPWpGaD
Epirubicin—Hypotension—Mesalazine—Crohn's disease	0.000532	0.000832	CcSEcCtD
Epirubicin—Pancreatitis—Prednisone—Crohn's disease	0.00052	0.000812	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000519	0.000811	CcSEcCtD
Epirubicin—DHCR7—Metabolism—FADS1—Crohn's disease	0.000516	0.00267	CbGpPWpGaD
Epirubicin—Feeling abnormal—Azathioprine—Crohn's disease	0.000515	0.000805	CcSEcCtD
Epirubicin—Insomnia—Mesalazine—Crohn's disease	0.000515	0.000805	CcSEcCtD
Epirubicin—Paraesthesia—Mesalazine—Crohn's disease	0.000512	0.000799	CcSEcCtD
Epirubicin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000511	0.000799	CcSEcCtD
Epirubicin—Dyspnoea—Mesalazine—Crohn's disease	0.000508	0.000793	CcSEcCtD
Epirubicin—Somnolence—Mesalazine—Crohn's disease	0.000507	0.000791	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000504	0.00261	CbGpPWpGaD
Epirubicin—Dyspepsia—Mesalazine—Crohn's disease	0.000502	0.000783	CcSEcCtD
Epirubicin—Neutropenia—Prednisone—Crohn's disease	0.000496	0.000774	CcSEcCtD
Epirubicin—Decreased appetite—Mesalazine—Crohn's disease	0.000495	0.000774	CcSEcCtD
Epirubicin—Abdominal pain—Azathioprine—Crohn's disease	0.000494	0.000772	CcSEcCtD
Epirubicin—Body temperature increased—Azathioprine—Crohn's disease	0.000494	0.000772	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000492	0.000768	CcSEcCtD
Epirubicin—YWHAG—ErbB1 downstream signaling—STAT3—Crohn's disease	0.000492	0.00255	CbGpPWpGaD
Epirubicin—Fatigue—Mesalazine—Crohn's disease	0.000491	0.000767	CcSEcCtD
Epirubicin—Constipation—Mesalazine—Crohn's disease	0.000487	0.000761	CcSEcCtD
Epirubicin—Pain—Mesalazine—Crohn's disease	0.000487	0.000761	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GPX4—Crohn's disease	0.000484	0.0025	CbGpPWpGaD
Epirubicin—Weight increased—Prednisone—Crohn's disease	0.000482	0.000754	CcSEcCtD
Epirubicin—Weight decreased—Prednisone—Crohn's disease	0.00048	0.000749	CcSEcCtD
Epirubicin—Hyperglycaemia—Prednisone—Crohn's disease	0.000478	0.000747	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.000475	0.00246	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000473	0.00245	CbGpPWpGaD
Epirubicin—Feeling abnormal—Mesalazine—Crohn's disease	0.00047	0.000733	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GCKR—Crohn's disease	0.000467	0.00242	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000466	0.000728	CcSEcCtD
Epirubicin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000463	0.000724	CcSEcCtD
Epirubicin—Hypersensitivity—Azathioprine—Crohn's disease	0.000461	0.00072	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.00046	0.00238	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—STAT3—Crohn's disease	0.000459	0.00237	CbGpPWpGaD
Epirubicin—Urticaria—Mesalazine—Crohn's disease	0.000453	0.000707	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	0.000451	0.00234	CbGpPWpGaD
Epirubicin—Abdominal pain—Mesalazine—Crohn's disease	0.00045	0.000703	CcSEcCtD
Epirubicin—Body temperature increased—Mesalazine—Crohn's disease	0.00045	0.000703	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000445	0.00231	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—STAT3—Crohn's disease	0.000432	0.00224	CbGpPWpGaD
Epirubicin—Bradycardia—Prednisone—Crohn's disease	0.000432	0.000675	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—ACKR2—Crohn's disease	0.000431	0.00223	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL1B—Crohn's disease	0.00043	0.00222	CbGpPWpGaD
Epirubicin—Diarrhoea—Azathioprine—Crohn's disease	0.000428	0.000668	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—Crohn's disease	0.000428	0.00221	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000427	0.00221	CbGpPWpGaD
Epirubicin—Haemoglobin—Prednisone—Crohn's disease	0.000426	0.000666	CcSEcCtD
Epirubicin—Haemorrhage—Prednisone—Crohn's disease	0.000424	0.000663	CcSEcCtD
Epirubicin—Hypersensitivity—Mesalazine—Crohn's disease	0.00042	0.000656	CcSEcCtD
Epirubicin—Connective tissue disorder—Prednisone—Crohn's disease	0.000417	0.000651	CcSEcCtD
Epirubicin—Dizziness—Azathioprine—Crohn's disease	0.000414	0.000646	CcSEcCtD
Epirubicin—Asthenia—Mesalazine—Crohn's disease	0.000409	0.000638	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—F5—Crohn's disease	0.000409	0.00212	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MLN—Crohn's disease	0.000408	0.00211	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—UBE2D1—Crohn's disease	0.000404	0.00209	CbGpPWpGaD
Epirubicin—Pruritus—Mesalazine—Crohn's disease	0.000403	0.00063	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000403	0.00208	CbGpPWpGaD
Epirubicin—Vomiting—Azathioprine—Crohn's disease	0.000398	0.000621	CcSEcCtD
Epirubicin—Eye disorder—Prednisone—Crohn's disease	0.000397	0.000619	CcSEcCtD
Epirubicin—Rash—Azathioprine—Crohn's disease	0.000394	0.000616	CcSEcCtD
Epirubicin—Dermatitis—Azathioprine—Crohn's disease	0.000394	0.000615	CcSEcCtD
Epirubicin—Flushing—Prednisone—Crohn's disease	0.000394	0.000615	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000393	0.00203	CbGpPWpGaD
Epirubicin—Headache—Azathioprine—Crohn's disease	0.000392	0.000612	CcSEcCtD
Epirubicin—Diarrhoea—Mesalazine—Crohn's disease	0.00039	0.000609	CcSEcCtD
Epirubicin—Angiopathy—Prednisone—Crohn's disease	0.000385	0.000601	CcSEcCtD
Epirubicin—Immune system disorder—Prednisone—Crohn's disease	0.000383	0.000599	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000383	0.00198	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000383	0.00198	CbGpPWpGaD
Epirubicin—Arrhythmia—Prednisone—Crohn's disease	0.000379	0.000592	CcSEcCtD
Epirubicin—Dizziness—Mesalazine—Crohn's disease	0.000377	0.000588	CcSEcCtD
Epirubicin—Alopecia—Prednisone—Crohn's disease	0.000375	0.000586	CcSEcCtD
Epirubicin—Mental disorder—Prednisone—Crohn's disease	0.000372	0.000581	CcSEcCtD
Epirubicin—Nausea—Azathioprine—Crohn's disease	0.000372	0.00058	CcSEcCtD
Epirubicin—Erythema—Prednisone—Crohn's disease	0.000369	0.000577	CcSEcCtD
Epirubicin—Malnutrition—Prednisone—Crohn's disease	0.000369	0.000577	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000368	0.0019	CbGpPWpGaD
Epirubicin—Vomiting—Mesalazine—Crohn's disease	0.000362	0.000566	CcSEcCtD
Epirubicin—Rash—Mesalazine—Crohn's disease	0.000359	0.000561	CcSEcCtD
Epirubicin—Dermatitis—Mesalazine—Crohn's disease	0.000359	0.000561	CcSEcCtD
Epirubicin—Headache—Mesalazine—Crohn's disease	0.000357	0.000557	CcSEcCtD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	0.000355	0.00184	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—JAK2—Crohn's disease	0.000353	0.00183	CbGpPWpGaD
Epirubicin—Vision blurred—Prednisone—Crohn's disease	0.000348	0.000544	CcSEcCtD
Epirubicin—Ill-defined disorder—Prednisone—Crohn's disease	0.000343	0.000535	CcSEcCtD
Epirubicin—Anaemia—Prednisone—Crohn's disease	0.000341	0.000533	CcSEcCtD
Epirubicin—Agitation—Prednisone—Crohn's disease	0.000339	0.00053	CcSEcCtD
Epirubicin—Nausea—Mesalazine—Crohn's disease	0.000338	0.000529	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000334	0.00173	CbGpPWpGaD
Epirubicin—Malaise—Prednisone—Crohn's disease	0.000333	0.00052	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	0.000333	0.00172	CbGpPWpGaD
Epirubicin—Vertigo—Prednisone—Crohn's disease	0.000332	0.000518	CcSEcCtD
Epirubicin—Syncope—Prednisone—Crohn's disease	0.000331	0.000517	CcSEcCtD
Epirubicin—Loss of consciousness—Prednisone—Crohn's disease	0.000325	0.000507	CcSEcCtD
Epirubicin—Convulsion—Prednisone—Crohn's disease	0.00032	0.0005	CcSEcCtD
Epirubicin—Hypertension—Prednisone—Crohn's disease	0.000319	0.000498	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	0.000316	0.00163	CbGpPWpGaD
Epirubicin—Arthralgia—Prednisone—Crohn's disease	0.000314	0.000491	CcSEcCtD
Epirubicin—Myalgia—Prednisone—Crohn's disease	0.000314	0.000491	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000314	0.00162	CbGpPWpGaD
Epirubicin—Anxiety—Prednisone—Crohn's disease	0.000313	0.000489	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000312	0.000488	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—TNF—Crohn's disease	0.000312	0.00161	CbGpPWpGaD
Epirubicin—Discomfort—Prednisone—Crohn's disease	0.000311	0.000485	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00031	0.00161	CbGpPWpGaD
Epirubicin—Oedema—Prednisone—Crohn's disease	0.000301	0.000471	CcSEcCtD
Epirubicin—Anaphylactic shock—Prednisone—Crohn's disease	0.000301	0.000471	CcSEcCtD
Epirubicin—Infection—Prednisone—Crohn's disease	0.000299	0.000468	CcSEcCtD
Epirubicin—Shock—Prednisone—Crohn's disease	0.000297	0.000463	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—Crohn's disease	0.000296	0.000462	CcSEcCtD
Epirubicin—Tachycardia—Prednisone—Crohn's disease	0.000294	0.00046	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000294	0.00152	CbGpPWpGaD
Epirubicin—Skin disorder—Prednisone—Crohn's disease	0.000293	0.000457	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000292	0.00151	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Prednisone—Crohn's disease	0.000291	0.000455	CcSEcCtD
Epirubicin—Anorexia—Prednisone—Crohn's disease	0.000287	0.000449	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR9—Crohn's disease	0.000283	0.00147	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—UBE2D1—Crohn's disease	0.000282	0.00146	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000275	0.000429	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000273	0.00141	CbGpPWpGaD
Epirubicin—Insomnia—Prednisone—Crohn's disease	0.000273	0.000426	CcSEcCtD
Epirubicin—Paraesthesia—Prednisone—Crohn's disease	0.000271	0.000423	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00027	0.0014	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	0.000269	0.00139	CbGpPWpGaD
Epirubicin—Dyspepsia—Prednisone—Crohn's disease	0.000265	0.000414	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—PLA2G4F—Crohn's disease	0.000264	0.00137	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GPR65—Crohn's disease	0.000263	0.00136	CbGpPWpGaD
Epirubicin—Decreased appetite—Prednisone—Crohn's disease	0.000262	0.000409	CcSEcCtD
Epirubicin—Fatigue—Prednisone—Crohn's disease	0.00026	0.000406	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—Crohn's disease	0.000259	0.00134	CbGpPWpGaD
Epirubicin—Constipation—Prednisone—Crohn's disease	0.000258	0.000403	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—ACKR2—Crohn's disease	0.000254	0.00132	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	0.000252	0.0013	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ITGA4—Crohn's disease	0.000251	0.0013	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.00025	0.0013	CbGpPWpGaD
Epirubicin—Feeling abnormal—Prednisone—Crohn's disease	0.000248	0.000388	CcSEcCtD
Epirubicin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000246	0.000385	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—IL3—Crohn's disease	0.000245	0.00127	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MLN—Crohn's disease	0.000241	0.00125	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.000241	0.00125	CbGpPWpGaD
Epirubicin—Urticaria—Prednisone—Crohn's disease	0.000239	0.000374	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000238	0.00123	CbGpPWpGaD
Epirubicin—Body temperature increased—Prednisone—Crohn's disease	0.000238	0.000372	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—Crohn's disease	0.000238	0.000372	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—RASGRP1—Crohn's disease	0.000237	0.00123	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000237	0.00123	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTMR3—Crohn's disease	0.000229	0.00118	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTMR3—Crohn's disease	0.000224	0.00116	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.000224	0.00116	CbGpPWpGaD
Epirubicin—Hypersensitivity—Prednisone—Crohn's disease	0.000222	0.000347	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—TAGAP—Crohn's disease	0.000221	0.00114	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RSPO3—Crohn's disease	0.00022	0.00114	CbGpPWpGaD
Epirubicin—Asthenia—Prednisone—Crohn's disease	0.000216	0.000338	CcSEcCtD
Epirubicin—Pruritus—Prednisone—Crohn's disease	0.000213	0.000333	CcSEcCtD
Epirubicin—ABCC1—Metabolism—PLA2G4F—Crohn's disease	0.000211	0.00109	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SEL1L—Crohn's disease	0.000209	0.00108	CbGpPWpGaD
Epirubicin—Diarrhoea—Prednisone—Crohn's disease	0.000206	0.000322	CcSEcCtD
Epirubicin—Dizziness—Prednisone—Crohn's disease	0.000199	0.000311	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—RSPO3—Crohn's disease	0.000193	0.000998	CbGpPWpGaD
Epirubicin—Vomiting—Prednisone—Crohn's disease	0.000192	0.000299	CcSEcCtD
Epirubicin—Rash—Prednisone—Crohn's disease	0.00019	0.000297	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—Crohn's disease	0.00019	0.000297	CcSEcCtD
Epirubicin—Headache—Prednisone—Crohn's disease	0.000189	0.000295	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR6—Crohn's disease	0.000188	0.000971	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LTF—Crohn's disease	0.000187	0.000969	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000184	0.000955	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SEL1L—Crohn's disease	0.000183	0.000946	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTMR3—Crohn's disease	0.000179	0.000928	CbGpPWpGaD
Epirubicin—Nausea—Prednisone—Crohn's disease	0.000179	0.00028	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—FADS1—Crohn's disease	0.000178	0.000923	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—FADS1—Crohn's disease	0.000175	0.000905	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2RA—Crohn's disease	0.000172	0.000889	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR9—Crohn's disease	0.000167	0.000866	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPX4—Crohn's disease	0.000167	0.000864	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTGER4—Crohn's disease	0.000165	0.000855	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPX4—Crohn's disease	0.000164	0.000847	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GCKR—Crohn's disease	0.000161	0.000834	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.00016	0.000827	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GCKR—Crohn's disease	0.000158	0.000818	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GPR65—Crohn's disease	0.000155	0.000805	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GCKR—Crohn's disease	0.000151	0.000781	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALB—Crohn's disease	0.000149	0.000769	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—Crohn's disease	0.000143	0.00074	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL3—Crohn's disease	0.000141	0.000728	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—FADS1—Crohn's disease	0.00014	0.000723	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000136	0.000704	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC11A1—Crohn's disease	0.000133	0.00069	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPX4—Crohn's disease	0.000131	0.000677	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PTGS2—Crohn's disease	0.00013	0.000673	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GCKR—Crohn's disease	0.000126	0.000654	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—Crohn's disease	0.000124	0.000642	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—JAK2—Crohn's disease	0.000115	0.000597	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RBX1—Crohn's disease	0.000114	0.000592	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HSPA1B—Crohn's disease	0.000114	0.000592	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000113	0.000585	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR6—Crohn's disease	0.000111	0.000573	CbGpPWpGaD
Epirubicin—ABCC1—Disease—UBE2D1—Crohn's disease	0.0001	0.000519	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RBX1—Crohn's disease	0.0001	0.000519	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.88e-05	0.000512	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2RA—Crohn's disease	9.85e-05	0.00051	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTGER4—Crohn's disease	9.75e-05	0.000505	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.03e-05	0.000467	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—UBE2D1—Crohn's disease	8.78e-05	0.000455	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	8.58e-05	0.000444	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RIPK2—Crohn's disease	8.52e-05	0.000441	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL3—Crohn's disease	8.31e-05	0.00043	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RASGRP1—Crohn's disease	8.03e-05	0.000416	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.9e-05	0.000409	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SOCS1—Crohn's disease	7.28e-05	0.000377	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SMAD3—Crohn's disease	7.17e-05	0.000371	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TYK2—Crohn's disease	6.94e-05	0.000359	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—JAK2—Crohn's disease	6.62e-05	0.000343	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SMAD3—Crohn's disease	6.28e-05	0.000325	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—Crohn's disease	6.04e-05	0.000313	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2RA—Crohn's disease	5.82e-05	0.000301	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—Crohn's disease	5.13e-05	0.000266	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—Crohn's disease	5.03e-05	0.00026	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TYK2—Crohn's disease	4.68e-05	0.000242	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—Crohn's disease	4.49e-05	0.000232	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JAK2—Crohn's disease	4.46e-05	0.000231	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—Crohn's disease	4.4e-05	0.000228	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—Crohn's disease	4.23e-05	0.000219	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—Crohn's disease	4.2e-05	0.000217	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TYK2—Crohn's disease	4.1e-05	0.000212	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—Crohn's disease	4.02e-05	0.000208	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JAK2—Crohn's disease	3.91e-05	0.000202	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—Crohn's disease	3.57e-05	0.000185	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—Crohn's disease	3.52e-05	0.000182	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—Crohn's disease	3.39e-05	0.000176	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—Crohn's disease	3.28e-05	0.00017	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—Crohn's disease	2.87e-05	0.000149	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—Crohn's disease	2.29e-05	0.000118	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—Crohn's disease	2.01e-05	0.000104	CbGpPWpGaD
